Surgical management of a hand extravasation of anthracycline at late presentation | Zendy

Komla Séna Amouzou | Zendy; Nabil Berny | Zendy; T M Haïdara | Zendy; A Chlihi | Zendy; M Ezzoubi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Surgical management of a hand extravasation of anthracycline at late presentation

Author(s) -

Komla Séna Amouzou,

Nabil Berny,

T M Haïdara,

A Chlihi,

M Ezzoubi

Publication year - 2017

Publication title -

journal of surgical dermatology

Language(s) - English

Resource type - Journals

eISSN - 2424-9165

pISSN - 2424-9084

DOI - 10.18282/jsd.v2.i2.111

Subject(s) - extravasation , anthracycline , epirubicin , medicine , chemotherapy , surgery , groin , presentation (obstetrics) , complication , breast cancer , tendon , cyclophosphamide , cancer , pathology

Anthracycline extravasation remains a feared serious complication of chemotherapy. At late presentation, deep ulceration and extensive soft tissue damage are seen. Hand extravasation of anthracycline may lead to tendon and nerves destruction with functional and economical impairments. We report a case of Epirubicin extravasation seen at day 25 in a 46-year-old woman treated for breast cancer. A groin flap failed due to the persistence of anthracyclin in the wound. A split thickness skin graft was done after all the tendons were removed. The chemotherapy was interrupted for two months. Wide serial debridements are needed to achieve the removal of all molecules of anthracycline that are observed when granulating tissue is observed permanently in the wound.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research